MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2006457
下载链接
链接失效反馈官方服务：
资源简介：
RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth.
PURPOSE: This phase I trial is studying the side effects and best dose of MS-275 in treating patients with advanced solid tumors or lymphoma.
作用原理：MS-275可通过阻断癌细胞生长所必需的酶，从而抑制癌细胞的增殖。试验目的：本Ⅰ期临床试验旨在探究MS-275治疗晚期实体瘤或淋巴瘤患者的不良反应与最佳给药剂量。
创建时间：
2001-03-15
